| Literature DB >> 34521104 |
Robby Nieuwlaat1,2, Wojtek Wiercioch1,2, Jan L Brozek1,2, Nancy Santesso1,2, Robert Kunkle3, Pablo Alonso-Coello4, David R Anderson5, Shannon M Bates6, Philipp Dahm7,8, Alfonso Iorio2,6, Wendy Lim6, Gary H Lyman9, Saskia Middeldorp10, Paul Monagle11,12,13,14, Reem A Mustafa2,15, Ignacio Neumann16, Thomas L Ortel17,18, Bram Rochwerg2,6, Sara K Vesely19, Daniel M Witt20, Adam Cuker21,22, Holger J Schünemann1,2,6.
Abstract
Trustworthy health guidelines should provide recommendations, document the development process, and highlight implementation information. Our objective was to develop a guideline manuscript template to help authors write a complete and useful report. The McMaster Grading of Recommendations Assessment, Development and Evaluation Centre collaborated with the American Society of Hematology (ASH) to develop guidelines for the management of venous thromboembolism. A template for reporting the guidelines was developed based on prior approaches and refined using input from other key stakeholders. The proposed guideline manuscript template includes: (1) title for guideline identification, (2) abstract, including a summary of key recommendations, (3) overview of all recommendations (executive summary), and (4) the main text, providing sufficient detail about the entire process, including objectives, background, and methodological decisions from panel selection and conflict-of-interest management to criteria for updating, as well as supporting information, such as links to online (interactive) tables. The template further allows for tailoring to the specific topic, using examples. Initial experience with the ASH guideline manuscript template was positive, and challenges included drafting descriptions of recommendations involving multiple management pathways, tailoring the template for a specific guideline, and choosing key recommendations to highlight. Feedback from a larger group of guideline authors and users will be needed to evaluate its usefulness and refine. The proposed guideline manuscript template is the first detailed template for transparent and complete reporting of guidelines. Consistent application of the template may simplify the preparation of an evidence-based guideline manuscript and facilitate its use.Entities:
Mesh:
Year: 2021 PMID: 34521104 PMCID: PMC8759117 DOI: 10.1182/bloodadvances.2020003577
Source DB: PubMed Journal: Blood Adv ISSN: 2473-9529
Guideline manuscript template conformation to reporting checklists
| Domain | GIN-McMaster checklist (step) | RIGHT (topic) | AGREE II (item) | Guideline manuscript template (page) |
|---|---|---|---|---|
|
| ||||
| Title | — | 1 | — | 1 |
| Authors | 15.3 | — | — | 1 |
| Abstract | — | — | — | 2 |
| Executive summary | — | 2 | 17 | 3 |
| Abbreviations and acronyms | — | 3 | — | 1 |
| Corresponding developer | — | 4 | — | 1 |
|
| ||||
| Brief description of the health problem | 2.9 | 5 | — | 6 |
| Aims of the guideline and specific objectives | 2.2 | 6 | 1 | 6 |
| Target populations | 8.3, 8.7 | 7 | 2 & 3 | 6 |
| End users and settings | 5 | 8 | 6 | 6 |
| Guideline development groups | 3 | 9 | 4 | 7 |
|
| ||||
| Health care questions | 8 | 10 | 2 | 9 |
| Systematic reviews | 10, 11 | 11 | 7, 8 | 9 |
| Assessment of the certainty of the body of evidence | 12 | 12 | 9 | 10 |
|
| ||||
| Recommendations | 13 & 14 | 13 | 10, 11, 15, 16, 20 | 13 |
| Rationale for recommendations | 13.6 | 14 | 5, 12, 20 | 13 |
| Evidence to decision process | 13.1 | 15 | 10, 12 | 9 |
|
| ||||
| External review | 15.7, 15.8 | 16 | 13 | 12 |
| Quality assurance | 15.6 | 17 | — | 12 |
|
| ||||
| Funding sources and roles of the funder | 7.6 | 18 | 22 | 7 |
| Declaration and management of interests | 7 | 19 | 23 | 7 |
|
| ||||
| Access | 16.1 | 20 | — | Whole document (eg, citation to guideline, links to EtDs with evidence profiles, and supplements) |
| Suggestions for further research | 13.5 | 21 | — | Each recommendation (EtD) |
| Limitations of the guideline | — | 22 | — | 15 |
| Updating the guideline | 18 | — | 14 | 16 |
| Applicability | 14.5 | 14 | 14 | Whole document (eg, feasibility, barriers for each recommendation) |
| Implementation | 16 | — | 18, 19 | Each recommendation (EtD) & 16 (local adaptation) |
| Monitoring | 17.3 | — | 21 | Each recommendation (EtD) |
Supplement 1; —, not addressed.